Visine Classic, 0.5 mg/ml, Eye Drops, Solution
Tetryzoline Hydrochloride
This medication should always be used exactly as described in this patient leaflet or as advised by your doctor or pharmacist.
Visine Classic eye drops are indicated for the symptomatic treatment of conditions with swelling and conjunctival hyperemia, resulting from irritation, e.g., by smoke, dust, wind, chlorinated water, cosmetics, as well as in allergic inflammatory conditions, such as hay fever or pollen allergy.
The eye drops relieve accompanying symptoms such as burning, itching, pain, excessive tearing, and irritation.
Before starting to use Visine Classic, discuss it with your doctor or pharmacist.
If you experience eye pain, vision disturbances, persistence or worsening of irritation or conjunctival hyperemia, or if symptoms do not improve, worsen, or new symptoms appear, discontinue use and consult your doctor.
Prolonged use or misuse of the medication may cause worsening or recurrence of hyperemia.
Use of the medication may cause temporary pupil dilation.
In patients with severe cardiovascular disorders (e.g., coronary artery disease, hypertension, pheochromocytoma) and/or metabolic disorders (e.g., diabetes, hyperthyroidism), treated with monoamine oxidase inhibitors (MAOIs) - also during the period up to 10 days after their discontinuation - and other medications that may increase blood pressure, as well as in patients with dry eye syndrome, keratitis, and glaucoma, the use of Visine Classic should be done after careful consideration of the potential benefits and risks.
In patients taking MAOI inhibitors and other medications that may increase blood pressure, Visine Classic should be used after consulting a doctor.
Consult your doctor before using Visine Classic with other eye medications.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before using this medication.
Due to possible systemic side effects, the use of Visine Classic in pregnant and breastfeeding women is possible only after careful consideration by the doctor of the risks and benefits associated with treatment.
No data are available on the passage of tetryzoline through the placental barrier and into breast milk.
Administration of Visine Classic may cause temporary blurred vision. In such cases, do not drive or operate machinery.
The medication contains 0.1 mg of benzalkonium chloride per milliliter.
Avoid contact between the medication and contact lenses.
Benzalkonium chloride may be absorbed by soft contact lenses and change their color. Remove contact lenses before instillation and wait at least 15 minutes before reinsertion.
Benzalkonium chloride may also cause eye irritation, especially in people with dry eye syndrome or corneal disorders (the transparent layer at the front of the eye). If you experience any abnormal sensations in the eye, stinging, or eye pain after using the medication, contact your doctor.
Do not use in children under 2 years of age due to the boron content, which may cause fertility disorders.
This medication should always be used exactly as described in this patient leaflet or as advised by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist.
Do not use in children under 2 years of age. In children aged 2-6 years, the use of the medication should be under medical supervision.
Unless otherwise advised by your doctor, instill 1 to 2 drops into the affected eye up to 3 times a day. Before instillation, remove contact lenses and wait at least 15 minutes after administration before reinsertion.
Use in children under 12 years of age should be under adult supervision.
The medication should not be used for more than 2 days. Use for more than 2 days should only be under medical supervision.
To avoid contamination of the medication, do not touch the tip of the applicator to any surface.
Discard the medication if it changes color or becomes cloudy.
Symptoms of overdose are usually not related to the administration of Visine Classic to the eye.
However, ingestion of the medication may cause serious side effects. In the case of ingestion of Visine Classic by an infant or small child, there is a risk of poisoning. Reported symptoms of overdose include: nausea, vomiting, lethargy, tachycardia, slowed breathing, bradycardia, hypotension, sedation, drowsiness, pupil dilation, stupor, hypothermia, salivation, coma.
Keep out of reach of children. In case of ingestion, seek medical help immediately.
Do not use a double dose to make up for a missed dose.
Like all medications, Visine Classic can cause side effects, although not everybody gets them.
The frequency of possible side effects listed below is defined as follows:
Common (more than 1 in 100 people but less than 1 in 10 people): vision disturbances and eye irritation (pain, stinging, burning).
Very rare (less than 1 in 10,000 people): increased tearing, pupil dilation, and reactions at the site of administration, including eye or eyelid burning, redness, irritation, swelling, pain, and itching.
Frequency not known (cannot be estimated from the available data): feeling of dryness in the eye and headache.
If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Medicinal Product Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Aleje Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309,
website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medication.
Store at a temperature below 30°C.
Keep the medication out of sight and reach of children.
Do not use this medication after the expiry date stated on the packaging.
The expiry date refers to the last day of the month stated.
The eye drops in the unopened factory-sealed bottle are sterile. After opening the bottle, the medication should be discarded after 1 month, even if not used.
Medications should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medications no longer required. This will help protect the environment.
A 15 ml LDPE bottle with an LDPE dropper and a PP cap, in a cardboard box.
A 15 ml LDPE bottle with an LDPE dropper and a PP/HDPE cap with a child-resistant closure, in a cardboard box.
Marketing authorization holder:
McNeil Healthcare (Ireland) Limited
Airton Road, Tallaght
Dublin 24
Ireland
Manufacturer:
Janssen Pharmaceutica N.V.
Turnhoutseweg 30
B-2340 Beerse
Belgium
To obtain more detailed information on this medication, contact:
Johnson & Johnson Poland Sp. z o.o.
ul. Iłżecka 24
02-135 Warsaw
tel.: 22 237 80 02
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.